Doctor profile · Federal record

Dr. David Hensley, M.D.

Dermatology Physician (CMS: Dermatology) · Arlington, TX

  • NPI 1144376419
  • Accepts Medicare
  • MIPS 99.3 / 100 · 2023
  • 31 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
300 W Arbrook Blvd, Suite D
Arlington, TX 760143105
(817) 701-4777
fax (817) 701-2323

Credentials & registration

NPPES · NUCC
NPI registered
January 2007 — 19 yrs on file
Profile last updated
June 15, 2020
Year of graduation
1995 — 31 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Texas #K2489

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1144376419. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
44,755
Distinct HCPCS
10
Medicare allowed
$900,281
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 30,400 54 $2
17003 Destruction of precancer skin growth, 2-14 growths 5,075 861 $7
99213 Established patient office or other outpatient visit, 20-29 minutes 2,955 1,806 $90
17000 Destruction of precancer skin growth, 1 growth 1,567 1,113 $55
17110 Destruction of skin growth, 1-14 growths 746 594 $112
11102 Biopsy of related skin growth, first growth 682 569 $93
99212 Established patient office or other outpatient visit, 10-19 minutes 646 536 $57
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 462 124 $1
99203 New patient office or other outpatient visit, 30-44 minutes 440 440 $111
99214 Established patient office or other outpatient visit, 30-39 minutes 291 231 $128

In context: peer comparison

Among 3 peers in Arlington Dermatology Physician, average services per provider: 793. This provider delivers 56× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$49,952
Transactions
258
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 28 $20,304.98
Abbvie INC. 47 $11,443.15
Lilly USA, LLC 14 $6,490.07
Sun Pharmaceutical Industries INC. 13 $4,272.40
Dermavant Sciences, INC. 19 $3,927.14
Janssen Biotech, INC. 26 $601.21
Incyte Corporation 14 $499.04
Genzyme Corporation 14 $443.59
Novartis Pharmaceuticals Corporation 12 $388.07
Pfizer INC. 26 $273.92
E.R. Squibb & Sons, L.L.C. 11 $225.09
Regeneron Healthcare Solutions, INC. 10 $212.92
Galderma Laboratories, L.P. 7 $210.92
Mayne Pharma Commercial LLC 8 $163.86
Ucb, INC. 9 $162.42

By nature of payment

Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$41,859
Food and Beverage
$5,856
Travel and Lodging
$1,998
Education
$239

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,311
Patients
865
Total drug cost
$200,657
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 226 154 $4,373
Doxycycline Hyclate Generic 210 159 $5,089
Ketoconazole Generic 165 112 $6,290
Clobetasol Propionate Generic 110 69 $6,616
Spironolactone Generic 94 30 $2,200
Hydrocortisone Generic 91 70 $801
Fluocinonide Generic 82 59 $4,477
Imiquimod Generic 80 61 $3,047
Betamethasone Dipropionate Generic 74 46 $4,235
Mupirocin Generic 38 30 $372

Frequently asked questions

Auto-generated from federal data
What is Dr. David Hensley's medical specialty?
Dr. David Hensley practices Dermatology Physician in Arlington, TX.
Where does Dr. David Hensley practice?
Dr. David Hensley practices at 300 W Arbrook Blvd, Arlington, TX 760143105. Office phone: 8177014777.
What is Dr. David Hensley's NPI?
Dr. David Hensley's National Provider Identifier (NPI) is 1144376419, issued by NPPES.
Does Dr. David Hensley accept Medicare assignment?
Yes. Dr. David Hensley accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Hensley commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.